Indivior Pharmaceuticals, Inc.
No trades
No trades
Price target
44.450.000.00%
The 6 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of E7P is 35.60 EUR — it hasn't changed in the past 24 hours. Watch Indivior Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Indivior Pharmaceuticals, Inc. stocks are traded under the ticker E7P.
E7P stock hasn't changed in a week, the month change is a 1.71% rise, over the last year Indivior Pharmaceuticals, Inc. has showed a 11.95% increase.
We've gathered analysts' opinions on Indivior Pharmaceuticals, Inc. future price: according to them, E7P price has a max estimate of 51.59 EUR and a min estimate of 40.22 EUR. Watch E7P chart and read a more detailed Indivior Pharmaceuticals, Inc. stock forecast: see what analysts think of Indivior Pharmaceuticals, Inc. and suggest that you do with its stocks.
E7P stock is 0.00% volatile and has beta coefficient of −0.45. Track Indivior Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Indivior Pharmaceuticals, Inc. there?
Today Indivior Pharmaceuticals, Inc. has the market capitalization of 4.45 B, it has increased by 0.29% over the last week.
Yes, you can track Indivior Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Indivior Pharmaceuticals, Inc. is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
E7P earnings for the last quarter are 0.83 EUR per share, whereas the estimation was 0.57 EUR resulting in a 45.45% surprise. The estimated earnings for the next quarter are 0.78 EUR per share. See more details about Indivior Pharmaceuticals, Inc. earnings.
Indivior Pharmaceuticals, Inc. revenue for the last quarter amounts to 274.37 M EUR, despite the estimated figure of 236.15 M EUR. In the next quarter, revenue is expected to reach 269.29 M EUR.
E7P net income for the last quarter is 77.03 M EUR, while the quarter before that showed 86.84 M EUR of net income which accounts for 0.00% change. Track more Indivior Pharmaceuticals, Inc. financial stats to get the full picture.
No, E7P doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 27, 2026, the company has 838 employees. See our rating of the largest employees — is Indivior Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Indivior Pharmaceuticals, Inc. EBITDA is 393.81 M EUR, and current EBITDA margin is 30.51%. See more stats in Indivior Pharmaceuticals, Inc. financial statements.
Like other stocks, E7P shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Indivior Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.